ACS Journal Cancer(@JournalCancer) 's Twitter Profileg
ACS Journal Cancer

@JournalCancer

An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)

ID:19077568

linkhttp://canceronlinejournal.com calendar_today16-01-2009 18:00:37

10,9K Tweets

29,6K Followers

4,5K Following

Follow People
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

New & available | The results of DREAMM-4 demonstrated clinical activity and a favorable safety profile of belamaf plus pembrolizumab in patients with relapsed or refractory multiple myeloma. Ajay Nooka, MD, MPH OncoAlert acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert

Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #BCSM
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

New from Tel Aviv University and Sheba Medical Center investigators | Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

OncoAlert Ruth O'Regan

New from @TelAvivUni and @sheba_medical investigators | Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @OncoAlert @oreganruth
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

The addition of daratumumab to the standard of care for patients with newly diagnosed significantly improved progression-free survival, reducing disease progression by 58% at 4 years.

Read more in our latest CancerScope: acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…

The addition of daratumumab to the standard of care for patients with newly diagnosed #MultipleMyeloma significantly improved progression-free survival, reducing disease progression by 58% at 4 years. Read more in our latest CancerScope: acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Patient preferences should be considered when making shared decisions about cancer therapy. In this analysis, City of Hope researchers explore outcome prioritization among older adults with cancer.

link: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Enrique Soto
OncoAlert

Patient preferences should be considered when making shared decisions about cancer therapy. In this analysis, @cityofhope researchers explore outcome prioritization among older adults with cancer. #OpenAccess link: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @EnriqueSoto8 @OncoAlert
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Parental social functioning is an indicator of well-being in early bereavement. Preparation for end of life and absence of household material hardships was associated with parental social functioning.

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

Jennifer Snaman Abby Rosenberg, MD, MS, MA OncoAlert

Parental social functioning is an indicator of well-being in early bereavement. Preparation for end of life and absence of household material hardships was associated with parental social functioning. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @JenniferSnaman @AbbyRosenbergMD @OncoAlert
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

its said that if you want to go fast go alone and
if you want to go far, go together

Our deepest gratitude to OUR 🚨PARTNERS
STRONGER TOGETHER‼️

ASTRO 🇺🇸
European Cancer Organisation 🇪🇺
American Cancer Society 🇺🇸Journals
➡️ACS Journal Cancer CA: A Cancer Journal for Clinicians 🇺🇸
MASCC 🌐
ABC Global Alliance

account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

The OncoAlert🚨NEWSLETTER OUT‼️
Covering April 12-18, 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

COVERING
✅NEW Prostate guidelines European Association of Urology (EAU)
✅The Lancet Commission
✅1st line Pembro & cemiplimab in🫁 🧪
✅RADICALS RT ☢️in…

account_circle
Jason Luke, MD, FACP(@jasonlukemd) 's Twitter Profile Photo

Thanks AACR for the profile. Hope all & interested folks will join the Cancer Immunology Working Group (CIMM), particularly on LinkedIn for on-going discussions of the field!

Thanks @AACR for the profile. Hope all #immunotherapy & #immunology interested folks will join the Cancer Immunology Working Group (CIMM), particularly on LinkedIn for on-going discussions of the field!
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

This new review article from Wei Ying Jen, Marina Konopleva, & Naveen Pemmaraju, MD is all about for . Learn how it is being used in combination to improve outcomes in BPDCN & AML, & its developing role in other hematological malignancies: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

This new review article from @jenweiying, @mkonople, & @doctorpemm is all about #tagraxofusp for #BPDCN. Learn how it is being used in combination to improve outcomes in BPDCN & AML, & its developing role in other hematological malignancies: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Just published! Top advances of the year: Uterine cancer acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

Over the last year, significant advances were achieved in improving oncologic outcomes by capitalizing on the molecular characterization of this heterogenous disease. These advances include:…

Just published! Top advances of the year: Uterine cancer acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Over the last year, significant advances were achieved in improving oncologic outcomes by capitalizing on the molecular characterization of this heterogenous disease. These advances include:…
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Our latest edition of CancerScope discusses dynamic risk prediction model for . Through deep learning, the model is able to adapt to future data, such as emerging treatment modalities and combinations.

acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…

OncoAlert Ajay Nooka, MD, MPH

account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

From our Breast Therapy in China Special Issue | Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert

From our Breast Therapy in China Special Issue | Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #BCSM
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Global phase 3 results presented at ASCO show that bevacizumab with immunotherapy has activity in . Our latest edition of CancerScope examines the findings: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert

Global phase 3 results presented at @ASCO #GI24 show that bevacizumab with immunotherapy has activity in #LiverCancer. Our latest edition of CancerScope examines the findings: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @OncoAlert #hpbcsm
account_circle
Wiley Oncology & Hematology(@WileyOnc_Hem) 's Twitter Profile Photo

A new special issue appearing in ACS Journal Cancer examines the achievements made in the field of in China in recent years and identifies gaps in the international field:

ow.ly/ZGTJ50ReBZc

American Cancer Society ACS Research

A new special issue appearing in @JournalCancer examines the achievements made in the field of #BreastCancer in China in recent years and identifies gaps in the international field: ow.ly/ZGTJ50ReBZc @AmericanCancer @ACS_Research
account_circle
NCI Cancer Stats(@NCICancerStats) 's Twitter Profile Photo

Researchers: Revisit our 2018 Annual Report to the Nation on the Status of Cancer, in which we describe an increase in late stage disease and leveling off of decline in mortality acsjournals.onlinelibrary.wiley.com/doi/full/10.10… in ACS Journal Cancer

account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

From our Breast Therapy in China Special Issue: Antibody–drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

@oncoalert

From our Breast Therapy in China Special Issue: Antibody–drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @oncoalert #BCSM
account_circle
Matthias Guckenberger(@Mat_Guc) 's Twitter Profile Photo

DOSIS - RCT in pts with painful vertebral mets
Hypothesis: improved LC -> durable pain response
First randomized trial with 6 mo pain reduction as prim endpoint
N=63 pts randomized to SBRT vs conv. RT
Significant benefit of SBRT: 69.4% vs. 41.9% (p=0.02)
doi.org/10.1002/cncr.3…

DOSIS - RCT in pts with painful vertebral mets Hypothesis: improved LC -> durable pain response First randomized trial with 6 mo pain reduction as prim endpoint N=63 pts randomized to SBRT vs conv. RT Significant benefit of SBRT: 69.4% vs. 41.9% (p=0.02) doi.org/10.1002/cncr.3…
account_circle